TrialClinical drug investigation2018

Riociguat for the Treatment of Raynaud's Phenomenon: A Single-Dose, Double-Blind, Randomized, Placebo-Controlled Cross-Over Pilot Study (DIGIT).

Michael Huntgeburth et al.PubMed ↗Publisher ↗

No numbers read from the abstract.